Interferon-γ and Colorectal Cancer: an up-to date.

Authors :: Kosmidis C
Sapalidis K
Koletsa T
Kosmidou M
Efthimiadis C
Anthimidis G
Varsamis N
Michalopoulos N
Koulouris C
Atmatzidis S
Liavas L
Strati TM
Koimtzis G
Tsakalidis A
Mantalovas S
Zarampouka K
Florou M
Giannakidis DE
Georgakoudi E
Baka S
Zarogoulidis P
Man YG
Kesisoglou I
Source :: Journal of Cancer [J Cancer] 2018 Jan 01; Vol. 9 (2), pp. 232-238. Date of Electronic Publication: 2018 Jan 01 (Print Publication: 2018).
Publication Year :: 2018
Abstract: Colorectal cancer still remains the third cause of cancer death among cancer patients. Early diagnosis is crucial and they can be either endoscopic or with blood biomarkers. Endoscopic methods consist of gastroscopy and colonoscopy, however; in recent years, endoscopic ultrasound is being used. The microenvironment is very important for the successful delivery of the treatment. Several proteins and hormones play a crucial role in the efficiency of the treatment. In the current mini review we will focus on interferon-γ.<br />Competing Interests: Competing Interests: The authors have declared that no competing interest exists.